UCLH
Welcome,         Profile    Billing    Logout  
 34 Trials 
87 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Ledermann, Jonathan A
ICON9, NCT03278717 / 2017-000161-75: Study Evaluating the Efficacy of Maintenance Olaparib and Cediranib or Olaparib Alone in Ovarian Cancer Patients

Recruiting
3
330
Europe, Canada, RoW
Olaparib, Cediranib
University College, London, Cancer Research UK, AstraZeneca UK Limited
Ovarian Cancer
12/23
12/23
NCT01398085 / 2011-000144-21: IoN- Is Ablative Radio-iodine Necessary for Low Risk Differentiated Thyroid Cancer Patients

Active, not recruiting
2/3
504
Europe
I131 1.1 GBq, Sodium iodide capsule
University College, London, Cancer Research UK
Thyroid Cancer
12/24
03/31
Janes, Sam
TACTICAL, NCT03298763: Targeted Stem Cells Expressing TRAIL as a Therapy for Lung Cancer

Recruiting
1/2
46
Europe
MSCTRAIL, Mesenchymal stromal cells genetically modified to express TRAIL, Placebo
University College, London
Adenocarcinoma of Lung
09/23
09/25
ASCENT, NCT04204499: Analysis of Screen-detected Lung Cancers' Genomic Traits

Recruiting
N/A
526
Europe
University College, London
Lung Cancer
08/25
03/26
Scully, Marie A
NCT04683003: A Study of TAK-755 in Participants With Congenital Thrombotic Thrombocytopenic Purpura

Recruiting
3
77
Europe, Japan, US, RoW
TAK-755, rADAMTS13; recombinant ADAMTS13; SHP-655; BAX 930
Takeda, Takeda Development Center Americas, Inc., Shire
Thrombotic Thrombocytopenic Purpura (TTP)
03/27
03/27
COVIPLEX, NCT04623255 / 2020-002668-29: Study of Plasma Exchange in Severe COVID-19

Completed
2
23
Europe
OCTAPLAS, plasma exchange
University College, London
COVID19
01/22
01/22
NCT05714969 / 2022-001940-36: A Study of TAK-755 (rADAMTS13) With Little to No Plasma Exchange (PEX) Treatment in Adults With Immune-mediated Thrombotic Thrombocytopenic Purpura (iTTP)

Active, not recruiting
2
40
Europe, US, RoW
TAK-755, rADAMTS13, recombinant ADAMTS13, SHP-655, BAX 930
Takeda, Takeda Development Center Americas, Inc.
Thrombotic Thrombocytopenic Purpura (TTP)
03/25
03/25
NCT03832881: The United Kingdom Thrombotic Thrombocytopenic Purpura Registry (UK TTP Registry)

Recruiting
N/A
1000
Europe
ADAMTS13, VWF assay
University College, London
TTP - Thrombotic Thrombocytopenic Purpura
11/23
11/23
Ahmed, Hashim Uddinn
IP2-ATLANTA, NCT03763253: Additional Treatments to the Local Tumour for Metastatic Prostate Cancer: Assessment of Novel Treatment Algorithms

Active, not recruiting
2
433
Europe
Standard of Care, Minimally Invasive Ablative Therapy (MIAT), Metastatic Directed Therapy (MDT), Radical Therapy (Prostatectomy or Radiotherapy)
Imperial College London, Wellcome Trust
Prostate Cancer, Metastatic Prostate Cancer
08/26
01/27
IP4-CHRONOS, NCT04049747: Comparative Health Research Outcomes of NOvel Surgery in Prostate Cancer

Recruiting
N/A
2450
Europe
Radical therapy (radiotherapy or prostatectomy [radiotherapy can be external beam or brachytherapy], radiotherapy, prostatectomy, external beam radiotherapy, brachytherapy, Focal therapy, high intensity focused ultrasound, cryotherapy, HIFU, Focal therapy after Finasteride 5Mg tablets for 12 weeks, Neoadjuvant, Focal therapy after Bicalutamide 50Mg tablets for 12 weeks
Imperial College London, Prostate Cancer UK, Imperial Clinical Trials Unit (ICTU)
Prostate Cancer, Non-metastatic Prostate Cancer, Prostate Adenocarcinoma
10/21
05/27
IP6-CHAIROS, NCT05228197: Imperial Prostate 6 - Cancer Histology Artificial Intelligence Reliability Study.

Recruiting
N/A
750
Europe
Biopsy & Imaging
Imperial College London, National Institute for Health Research, United Kingdom
Prostatic Neoplasms
07/24
12/24
NCT05684809: Efficacy of Mobilization With Post- Isometric Relaxation in Neck Pain Associated With Myofascial Trigger Points

Completed
N/A
33
RoW
Post Isometric relaxation Technique (PIR), Cervical Mobilization (CM), conventional treatment
Najran University
Mechanical Neck Pain
01/23
02/23
IP5-MATTER, NCT04590976: Metastatic Prostate Cancer Men's Attitudes Towards Treatment of the Local Tumour and Metastasis Evaluative Research

Completed
N/A
320
Europe
Semi-Structured Interview Healthcare Professional, Semi-Structured Interview Patients, Think Aloud Interview Patients, Discrete Choice Experiment (DCE) Patients
Imperial College London, University of Aberdeen
Prostate Cancer Metastatic, Radiotherapy Side Effect, Surgery, Urologic Cancer, Quality of Life, Patient Satisfaction, Health Care Utilization
02/23
02/23
MIND-P, NCT04647474: Mental Wellbeing and Quality of Life in Prostate Cancer

Completed
N/A
300
Europe
King's College London, King's College Hospital NHS Trust, Guy's and St Thomas' NHS Foundation Trust, Imperial College Healthcare NHS Trust, Medway NHS Foundation Trust, Lewisham and Greenwich NHS Trust, Surrey and Sussex Healthcare NHS Trust, Bedfordshire Hospitals NHS Foundation Trust
Prostate Cancer
03/23
03/23
NCT05708781: Efficacy of Core Strengthening and Intensive Dynamic Back Exercises in Patient With Low Back Pain

Completed
N/A
45
RoW
Core strengthening exercise, intensive dynamic back exercise, Control group
Najran University
Low Back Pain
08/23
09/23
NCT06062459: Synergistic Benefits of MCE and BT in Sacroiliac Joint Dysfunction: A Randomized Controlled Trial

Completed
N/A
120
RoW
Motor Control Exercise, Balance Training, Control Group
Najran University
Sacroiliac Joint Dysfunction
08/23
09/23
NCT06099860: Therapeutic Impact of KT Along With BT in Patients With Chronic Low Back Pain of Sacroiliac Joint Dysfunction

Completed
N/A
30
RoW
Kinesio Taping, Balance Training (BT), Hot Pack and Stretching Exercises
Najran University
Sacroiliac Joint Dysfunction
09/23
10/23
IP9-ATLAS, NCT06280781: Imperial Prostate 9 - ATLAS (Approaches To Long-Term Active Surveillance)

Recruiting
N/A
1263
Europe
MRI Scans
Imperial College Healthcare NHS Trust, East London NHS Foundation Trust, King's College, University College, London, University of York, University College London Hospitals
Prostate Cancer
06/29
06/32
NCT06569615: Efficacy of Extracorporeal Shock Wave Therapy, LASER Therapy and Cryotherapy in Patients Having Sacroiliitis

Not yet recruiting
N/A
60
RoW
shock wave therapy, LASER Therapy, Cryotherapy, Exercises
Najran University
Sacroilitis
02/25
02/25
NCT04060589: ReIMAGINE Prostate Cancer Risk

Active, not recruiting
N/A
1000
Europe
Tissue donation, Blood Donation, Urine Donation, Healthcare data linkage
University College, London, Medical Research Council, Cancer Research UK, Imperial College London, King's College London
Prostate Cancer
05/25
05/25
IP7-PACIFIC, NCT05574647: Imperial Prostate 7 - Prostate Assessment Using Comparative Interventions - Fast Mri and Image-fusion for Cancer

Recruiting
N/A
3600
Europe
bpMRI, biparametric MRI, Image-Fusion targeted and systematic Biopsy
Imperial College London, Cancer Research UK, National Institute for Health Research, United Kingdom
Prostate Cancer, Adenocarcinoma, Prostatic Neoplasms, Prostatic Diseases, Neoplasms
10/25
01/26
NCT01194648: Focal Therapy for Prostate Cancer Using HIFU

Recruiting
N/A
354
Europe
questionnaire administration, assessment of therapy complications, high-intensity focused ultrasound ablation, multiparametric magnetic resonance imaging, quality-of-life assessment, transperineal prostate biopsy, transrectal prostate biopsy
University College, London
Male Erectile Disorder, Prostate Cancer, Therapy-related Toxicity, Urinary Incontinence
12/28
06/29
Kelly, John
iROC, NCT03049410: Trial to Compare Robotically Assisted Radical Cystectomy With Open Radical Cystectomy

Active, not recruiting
3
339
Europe
Intracorporeal Robot Assisted Radical Cystectomy, Open Radical Cystectomy
University College, London
Bladder Cancer
09/21
12/21
NCT05711940: Efficacy, Safety, and Tolerability of Two Administrations of COMP360 in Participants With TRD

Recruiting
3
568
Europe, Canada, US, RoW
Psilocybin, COMP360
COMPASS Pathways
Treatment Resistant Depression
03/25
05/25
NCT05481736: Efficacy and Safety of COMP360 Psilocybin Therapy in Anorexia Nervosa: a Proof-of-concept Study

Completed
2
32
Europe, US
Psilocybin, COMP360
COMPASS Pathways
Anorexia Nervosa
11/24
11/24
HIVECII, NCT06768346: Hyperthermic Intra-Vesical Chemotherapy

Completed
N/A
259
Europe
Hyperthermia will be delivered in combination with each instillation using the Combat BRS system
Queen Mary University of London
Bladder Cancer
05/20
05/20
InTEGRA, NCT06395467: 12-Step Facilitation/MET/CBT () vs. MET/CBT for Youth With Alcohol and Other Drug Use Disorder

Not yet recruiting
N/A
294
US
InTEGRA, MET/CBT
Massachusetts General Hospital, National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Alcohol Use Disorder, Cannabis Use Disorder
04/27
04/27
HALO-Trak, NCT05971277: Home And Locally Observed - Tracking

Recruiting
N/A
200
Europe
Halo Wearable data device
University College, London
Advanced Cancer
04/25
04/26
Taylor, Sarah
NCT04377087: Delayed Initiation of Olaparib Maintenance Therapy in Platinum Sensitive Recurrent Ovarian Cancer

Terminated
2
3
US
Olaparib, Lynparza™
Sarah E Taylor, American Society of Clinical Oncology
Ovarian Cancer
05/23
05/23
NCT06126276: Testing the Use of Neratinib or the Combination of Neratinib and Palbociclib Targeted Treatment for HER2+ Solid Tumors (A ComboMATCH Treatment Trial)

Recruiting
2
70
US
Biopsy, BIOPSY_TYPE, Bx, Biospecimen Collection, Biological Sample Collection, Biospecimen Collected, Specimen Collection, Computed Tomography, CAT, CAT Scan, Computed Axial Tomography, Computerized Axial Tomography, Computerized axial tomography (procedure), Computerized Tomography, Computerized Tomography (CT) scan, CT, CT Scan, tomography, Echocardiography, EC, Magnetic Resonance Imaging, Magnetic Resonance, Magnetic Resonance Imaging (MRI), Magnetic resonance imaging (procedure), Magnetic Resonance Imaging Scan, Medical Imaging, Magnetic Resonance / Nuclear Magnetic Resonance, MR, MR Imaging, MRI, MRI Scan, MRIs, NMR Imaging, NMRI, Nuclear Magnetic Resonance Imaging, sMRI, Structural MRI, Multigated Acquisition Scan, Blood Pool Scan, Equilibrium Radionuclide Angiography, Gated Blood Pool Imaging, Gated Heart Pool Scan, MUGA, MUGA Scan, Multi-Gated Acquisition Scan, Radionuclide Ventriculogram Scan, Radionuclide Ventriculography, RNV Scan, RNVG, SYMA Scanning, Synchronized Multigated Acquisition Scanning, Neratinib Maleate, 2-Butenamide, N-(4-((3-chloro-4-(2-pyridinylmethoxy)phenyl)amino)-3-cyano-7-ethoxy-6-quinolinyl)-4-(dimethylamino)-, (2E)-, (2Z)-2-butenedioate (1:1), HKI-272 Maleate, NERATINIB MALEATE ANHYDROUS, Nerlynx, Palbociclib, 6-Acetyl-8-cyclopentyl-5-methyl-2-((5-(piperazin-1-yl)pyridin-2-yl)amino)-8h-pyrido(2,3-d)pyrimidin-7-one, Ibrance, PD 0332991, PD 332991, PD 991, PD-0332991, PD0332991
National Cancer Institute (NCI)
Malignant Female Reproductive System Neoplasm, Malignant Solid Neoplasm, Recurrent Malignant Female Reproductive System Neoplasm, Recurrent Malignant Solid Neoplasm
04/25
04/25
ComboMATCH, NCT05554380: Study of Chemotherapy Plus Ipatasertib for People With Solid Tumors With PTEN/AKT Mutations, A Treatment Trial

Recruiting
2
33
US
Biopsy, BIOPSY_TYPE, Bx, Biospecimen Collection, Biological Sample Collection, Biospecimen Collected, Specimen Collection, Computed Tomography, CAT, CAT Scan, Computed Axial Tomography, Computerized Axial Tomography, Computerized axial tomography (procedure), Computerized Tomography, Computerized Tomography (CT) scan, CT, CT Scan, tomography, Ipatasertib, GDC 0068, GDC-0068, GDC0068, RG 7440, RG-7440, RG7440, Magnetic Resonance Imaging, Magnetic Resonance, Magnetic Resonance Imaging (MRI), Magnetic resonance imaging (procedure), Magnetic Resonance Imaging Scan, Medical Imaging, Magnetic Resonance / Nuclear Magnetic Resonance, MR, MR Imaging, MRI, MRI Scan, MRIs, NMR Imaging, NMRI, Nuclear Magnetic Resonance Imaging, sMRI, Structural MRI, Paclitaxel, Anzatax, Asotax, Bristaxol, Praxel, Taxol, Taxol Konzentrat
National Cancer Institute (NCI)
Locally Advanced Malignant Solid Neoplasm, Metastatic Malignant Solid Neoplasm, Unresectable Malignant Solid Neoplasm
08/25
08/25
NCT05554367: Palbociclib and Binimetinib in RAS-Mutant Cancers, A ComboMATCH Treatment Trial

Recruiting
2
199
US
Binimetinib, ARRY 162, ARRY 438162, ARRY-162, ARRY-438162, ARRY162, ARRY438162, MEK 162, MEK-162, MEK162, Mektovi, Biopsy, BIOPSY_TYPE, Bx, Biospecimen Collection, Biological Sample Collection, Biospecimen Collected, Specimen Collection, Bone Scan, Bone Scintigraphy, Computed Tomography, CAT, CAT Scan, Computed Axial Tomography, Computerized Axial Tomography, Computerized axial tomography (procedure), Computerized Tomography, Computerized Tomography (CT) scan, CT, CT Scan, tomography, Magnetic Resonance Imaging, Magnetic Resonance, Magnetic Resonance Imaging (MRI), Magnetic resonance imaging (procedure), Magnetic Resonance Imaging Scan, Medical Imaging, Magnetic Resonance / Nuclear Magnetic Resonance, MR, MR Imaging, MRI, MRI Scan, MRIs, NMR Imaging, NMRI, Nuclear Magnetic Resonance Imaging, sMRI, Structural MRI, Palbociclib, 6-Acetyl-8-cyclopentyl-5-methyl-2-((5-(piperazin-1-yl)pyridin-2-yl)amino)-8h-pyrido(2,3-d)pyrimidin-7-one, Ibrance, PD 0332991, PD 332991, PD 991, PD-0332991, PD0332991
National Cancer Institute (NCI)
Exocrine Pancreas Carcinoma, Malignant Solid Neoplasm, Ovarian Low Grade Serous Adenocarcinoma, Stage IV Ovarian Cancer AJCC v8, Stage IV Pancreatic Cancer AJCC v8
08/26
08/26
Inbraced, NCT02914405 / 2016-002221-11: Phase I Study of 131-I MIBG Followed by Nivolumab & Dinutuximab Beta Antibodies in Children with Relapsed/refractory Neuroblastoma

Active, not recruiting
1
44
Europe, US
Nivolumab, BMS-936558, MDX1106, ONO-4538, anti-PD-1) NSC#748726, IND #124729, Ch14.18/CHO, Mouse-human chimeric monoclonal anti-GD2 Immunoglobulin G1 (IgG1) antibody
University Hospital Southampton NHS Foundation Trust, University College London Hospitals, University of Wisconsin, Madison, University Hospital Greifswald, Solving Kids' Cancer US/EU, Joining Against Cancer in Kids, The Band of Parents
Neuroblastoma
05/25
07/25
CX-5461-04, NCT04890613: Study of CX-5461 in Patients With Solid Tumours and BRCA1/2, PALB2 or Homologous Recombination Deficiency (HRD) Mutation

Recruiting
1
52
Canada, US
CX-5461, Pidnarulex
Senhwa Biosciences, Inc.
Advanced Solid Tumor
12/24
06/25
NCT02595879: Triapine With Chemotherapy and Radiation Therapy in Treating Patients With IB2-IVA Cervical or Vaginal Cancer

Active, not recruiting
1
21
US
Biospecimen Collection, Biological Sample Collection, Biospecimen Collected, Specimen Collection, Brachytherapy, Brachytherapy, NOS, Internal Radiation, Internal Radiation Brachytherapy, Internal Radiation Therapy, Radiation Brachytherapy, Radiation, Internal, Cisplatin, Abiplatin, Blastolem, Briplatin, CDDP, Cis-diammine-dichloroplatinum, Cis-diamminedichloridoplatinum, Cis-diamminedichloro Platinum (II), Cis-diamminedichloroplatinum, Cis-dichloroammine Platinum (II), Cis-platinous Diamine Dichloride, Cis-platinum, Cis-platinum II, Cis-platinum II Diamine Dichloride, Cismaplat, Cisplatina, Cisplatinum, Cisplatyl, Citoplatino, Citosin, Cysplatyna, DDP, Lederplatin, Metaplatin, Neoplatin, Peyrone's Chloride, Peyrone's Salt, Placis, Plastistil, Platamine, Platiblastin, Platiblastin-S, Platinex, Platinol, Platinol- AQ, Platinol-AQ, Platinol-AQ VHA Plus, Platinoxan, Platinum, Platinum Diamminodichloride, Platiran, Platistin, Platosin, Computed Tomography, CAT, CAT Scan, Computed Axial Tomography, Computerized Axial Tomography, Computerized axial tomography (procedure), Computerized Tomography, Computerized Tomography (CT) scan, CT, CT Scan, tomography, External Beam Radiation Therapy, Definitive Radiation Therapy, EBRT, External Beam Radiation, External Beam Radiotherapy, External Beam Radiotherapy (conventional), External Beam RT, external radiation, External Radiation Therapy, external-beam radiation, Radiation, External Beam, Teleradiotherapy, Teletherapy, Teletherapy Radiation, Fludeoxyglucose F-18, 18FDG, FDG, Fludeoxyglucose (18F), fludeoxyglucose F 18, Fludeoxyglucose F18, Fluorine-18 2-Fluoro-2-deoxy-D-Glucose, Fluorodeoxyglucose F18, High-Dose Rate Brachytherapy, Brachytherapy, High Dose, HDR, High dose brachytherapy (procedure), Intensity-Modulated Radiation Therapy, IMRT, Intensity modulated radiation therapy (procedure), Intensity Modulated RT, Intensity-Modulated Radiotherapy, Radiation, Intensity-Modulated Radiotherapy, Magnetic Resonance Imaging, Magnetic Resonance, Magnetic Resonance Imaging (MRI), Magnetic resonance imaging (procedure), Magnetic Resonance Imaging Scan, Medical Imaging, Magnetic Resonance / Nuclear Magnetic Resonance, MR, MR Imaging, MRI, MRI Scan, MRIs, NMR Imaging, NMRI, Nuclear Magnetic Resonance Imaging, sMRI, Structural MRI, Pharmacological Study, Positron Emission Tomography, Medical Imaging, Positron Emission Tomography, PET, PET Scan, Positron emission tomography (procedure), Positron Emission Tomography Scan, Positron-Emission Tomography, proton magnetic resonance spectroscopic imaging, PT, Triapine, 3-aminopyridine-2-carboxaldehyde thiosemicarbazone, 3-AP, 3-Apct, OCX-0191, OCX-191, OCX191, PAN-811
National Cancer Institute (NCI)
Advanced Cervical Adenocarcinoma, Advanced Cervical Adenosquamous Carcinoma, Advanced Cervical Squamous Cell Carcinoma, Advanced Vaginal Adenocarcinoma, Advanced Vaginal Adenosquamous Carcinoma, Advanced Vaginal Squamous Cell Carcinoma, Stage IB2 Cervical Cancer AJCC v6 and v7, Stage II Cervical Cancer AJCC v7, Stage II Vaginal Cancer AJCC v6 and v7, Stage III Vaginal Cancer AJCC v6 and v7, Stage IIIB Cervical Cancer AJCC v6 and v7, Stage IVA Cervical Cancer AJCC v6 and v7, Stage IVA Vaginal Cancer AJCC v6 and v7
06/23
04/25
NCT04840589: Testing the Combination of ZEN003694 and Nivolumab With or Without Ipilimumab in Solid Tumors

Recruiting
1
66
US
BET Bromodomain Inhibitor ZEN-3694, BETi ZEN-3694, ZEN 3694, ZEN-3694, ZEN003694, Biopsy, BIOPSY_TYPE, Bx, Biospecimen Collection, Biological Sample Collection, Biospecimen Collected, Specimen Collection, Computed Tomography, CAT, CAT Scan, Computed Axial Tomography, Computerized Axial Tomography, Computerized axial tomography (procedure), Computerized Tomography, Computerized Tomography (CT) scan, CT, CT Scan, tomography, Ipilimumab, Anti-Cytotoxic T-Lymphocyte-Associated Antigen-4 Monoclonal Antibody, BMS 734016, BMS-734016, BMS734016, Ipilimumab Biosimilar CS1002, MDX 010, MDX-010, MDX-CTLA4, MDX010, Yervoy, Magnetic Resonance Imaging, Magnetic Resonance, Magnetic Resonance Imaging (MRI), Magnetic resonance imaging (procedure), Magnetic Resonance Imaging Scan, Medical Imaging, Magnetic Resonance / Nuclear Magnetic Resonance, MR, MR Imaging, MRI, MRI Scan, MRIs, NMR Imaging, NMRI, Nuclear Magnetic Resonance Imaging, sMRI, Structural MRI, Nivolumab, ABP 206, BCD-263, BMS 936558, BMS-936558, BMS936558, CMAB819, MDX 1106, MDX-1106, MDX1106, NIVO, Nivolumab Biosimilar ABP 206, Nivolumab Biosimilar BCD-263, Nivolumab Biosimilar CMAB819, ONO 4538, ONO-4538, ONO4538, Opdivo, Positron Emission Tomography, Medical Imaging, Positron Emission Tomography, PET, PET Scan, Positron emission tomography (procedure), Positron Emission Tomography Scan, Positron-Emission Tomography, proton magnetic resonance spectroscopic imaging, PT, X-Ray Imaging, Conventional X-Ray, Diagnostic Radiology, Medical Imaging, X-Ray, Plain film radiographs, Radiographic Imaging, Radiographic imaging procedure (procedure), Radiography, RG, Static X-Ray, X-Ray
National Cancer Institute (NCI)
Metastatic Malignant Solid Neoplasm, Recurrent Malignant Solid Neoplasm, Recurrent Platinum-Resistant Ovarian Carcinoma, Refractory Ovarian Carcinoma
01/26
01/26
NCI10217, NCT03842228: Testing the Combination of the Anti-cancer Drugs Copanlisib, Olaparib, and MEDI4736 (Durvalumab) in Patients With Advanced Solid Tumors With Selected Mutations

Active, not recruiting
1
108
US
Biopsy, BIOPSY_TYPE, Bx, Biospecimen Collection, Biological Sample Collection, Biospecimen Collected, Specimen Collection, Computed Tomography, CAT, CAT Scan, Computed Axial Tomography, Computerized Axial Tomography, Computerized axial tomography (procedure), Computerized Tomography, Computerized Tomography (CT) scan, CT, CT Scan, tomography, Copanlisib Hydrochloride, 5-Pyrimidinecarboxamide, 2-Amino-N-(2,3-dihydro-7-methoxy-8-(3-(4-morpholinyl)propoxy)imidazo(1,2-C)quinazolin-5-yl)-, Hydrochloride (1:2), Aliqopa, BAY 80-6946 Dihydrochloride, BAY-80-6946 Dihydrochloride, Copanlisib Dihydrochloride, Durvalumab, Imfinzi, Immunoglobulin G1, Anti-(Human Protein B7-H1) (Human Monoclonal MEDI4736 Heavy Chain), Disulfide with Human Monoclonal MEDI4736 Kappa-chain, Dimer, MEDI 4736, MEDI-4736, MEDI4736, Echocardiography, EC, Magnetic Resonance Imaging, Magnetic Resonance, Magnetic Resonance Imaging (MRI), Magnetic resonance imaging (procedure), Magnetic Resonance Imaging Scan, Medical Imaging, Magnetic Resonance / Nuclear Magnetic Resonance, MR, MR Imaging, MRI, MRI Scan, MRIs, NMR Imaging, NMRI, Nuclear Magnetic Resonance Imaging, sMRI, Structural MRI, Olaparib, AZD 2281, AZD-2281, AZD2281, KU 0059436, KU-0059436, KU0059436, Lynparza, Olanib, Olaparix, PARP Inhibitor AZD2281, X-Ray Imaging, Conventional X-Ray, Diagnostic Radiology, Medical Imaging, X-Ray, Plain film radiographs, Radiographic Imaging, Radiographic imaging procedure (procedure), Radiography, RG, Static X-Ray, X-Ray
National Cancer Institute (NCI)
Advanced Malignant Solid Neoplasm, Metastatic Malignant Solid Neoplasm, Unresectable Malignant Solid Neoplasm
12/24
12/24
SL03-OHD-105, NCT05483933: Phase 1b Study of SL-172154 Administered with Combination Agent(s) in Subjects with Ovarian Cancers

Active, not recruiting
1
86
Europe, Canada, US
Pegylated Liposomal Doxorubicin + SL-172154, Doxil, PLD, Caelyx, Mirvetuximab + SL-172154, IMGN853, MIRV
Shattuck Labs, Inc.
Platinum-resistant Ovarian Cancer, Fallopian Tube Cancer, Epithelial Ovarian Cancer, Ovarian Cancer, Platinum-Resistant Fallopian Tube Carcinoma, Platinum-Resistant Primary Peritoneal Carcinoma, Primary Peritoneal Carcinoma
11/24
11/24
NCT04092270: A Study Combining the Peposertib (M3814) Pill With Standard Chemotherapy in Patients With Ovarian Cancer With an Expansion in High Grade Serous Ovarian Cancer and Low Grade Serous Ovarian Cancer

Active, not recruiting
1
54
US
Biospecimen Collection, Biological Sample Collection, Biospecimen Collected, Specimen Collection, Computed Tomography, CAT, CAT Scan, Computed Axial Tomography, Computerized Axial Tomography, Computerized axial tomography (procedure), Computerized Tomography, Computerized Tomography (CT) scan, CT, CT Scan, tomography, Echocardiography, EC, Magnetic Resonance Imaging, Magnetic Resonance, Magnetic Resonance Imaging (MRI), Magnetic resonance imaging (procedure), Magnetic Resonance Imaging Scan, Medical Imaging, Magnetic Resonance / Nuclear Magnetic Resonance, MR, MR Imaging, MRI, MRI Scan, MRIs, NMR Imaging, NMRI, Nuclear Magnetic Resonance Imaging, sMRI, Structural MRI, Multigated Acquisition Scan, Blood Pool Scan, Equilibrium Radionuclide Angiography, Gated Blood Pool Imaging, Gated Heart Pool Scan, MUGA, MUGA Scan, Multi-Gated Acquisition Scan, Radionuclide Ventriculogram Scan, Radionuclide Ventriculography, RNV Scan, RNVG, SYMA Scanning, Synchronized Multigated Acquisition Scanning, Pegylated Liposomal Doxorubicin Hydrochloride, ATI-0918, Caelyx, Dox-SL, Doxil, Doxilen, Doxorubicin HCl Liposomal, Doxorubicin HCl Liposome, Doxorubicin Hydrochloride Liposome, Duomeisu, Evacet, LipoDox, Lipodox 50, Liposomal Adriamycin, Liposomal Doxorubicin Hydrochloride, Liposomal-Encapsulated Doxorubicin, Pegylated Doxorubicin HCl Liposome, Pegylated Liposomal Doxorubicin, S-Liposomal Doxorubicin, Stealth Liposomal Doxorubicin, TLC D-99, Peposertib, 3-Pyridazinemethanol, alpha-(2-Chloro-4-fluoro-5-(7-(4-morpholinyl)-4-quinazolinyl)phenyl)-6-methoxy-, (alphaS)-, M 3814, M-3814, M3814, MSC 2490484A, MSC-2490484A, MSC2490484A, Nedisertib
National Cancer Institute (NCI)
Endometrial High Grade Endometrioid Adenocarcinoma, Fallopian Tube Carcinosarcoma, Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube High Grade Serous Adenocarcinoma, Fallopian Tube Mucinous Adenocarcinoma, Fallopian Tube Transitional Cell Carcinoma, Fallopian Tube Undifferentiated Carcinoma, FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma, FIGO Grade 2 Endometrial Endometrioid Adenocarcinoma, Ovarian High Grade Serous Adenocarcinoma, Ovarian Seromucinous Carcinoma, Ovarian Undifferentiated Carcinoma, Platinum-Sensitive Ovarian Carcinoma, Primary Peritoneal Carcinosarcoma, Primary Peritoneal High Grade Serous Adenocarcinoma, Primary Peritoneal Transitional Cell Carcinoma, Primary Peritoneal Undifferentiated Carcinoma, Recurrent Fallopian Tube Carcinoma, Recurrent Low Grade Fallopian Tube Serous Adenocarcinoma, Recurrent Ovarian Carcinoma, Recurrent Ovarian Carcinosarcoma, Recurrent Ovarian Clear Cell Adenocarcinoma, Recurrent Ovarian Endometrioid Adenocarcinoma, Recurrent Ovarian Low Grade Serous Adenocarcinoma, Recurrent Ovarian Mucinous Adenocarcinoma, Recurrent Ovarian Transitional Cell Carcinoma, Recurrent Primary Peritoneal Carcinoma, Recurrent Primary Peritoneal Low Grade Serous Adenocarcinoma
06/25
06/25
NRG-GY022, NCT03997370: Evaluation of Dosing Procedures of Chemotherapy Treatment (Carboplatin) With the Contrast Agent Iohexol

Recruiting
1
350
US
Biospecimen Collection, Biological Sample Collection, Biospecimen Collected, Specimen Collection, Carboplatin, Blastocarb, Carboplat, Carboplatin Hexal, Carboplatino, Carboplatinum, Carbosin, Carbosol, Carbotec, CBDCA, Displata, Ercar, JM-8, JM8, Nealorin, Novoplatinum, Paraplatin, Paraplatin AQ, Paraplatine, Platinwas, Ribocarbo, Iohexol, Omnipaque
NRG Oncology, National Cancer Institute (NCI)
Malignant Solid Neoplasm
02/27
02/28
NCT05380401: Metabolic Mechanisms Induced by Enteral DHA and ARA Supplementation in Preterm Infants

Recruiting
N/A
328
US
Enfamil® DHA & ARA Supplement for Special Dietary Use, DHA/ARA Supplement
The University of Texas Health Science Center at San Antonio, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Premature
04/27
04/28
Lee, Don Haeng
PHOENIX, NCT03849586: Registry for Patients Undergoing Penile Prosthesis Implantation for Male Erectile Dysfunction

Active, not recruiting
N/A
1076
Europe
European Association of Urology Research Foundation, Boston Scientific Corporation, Coloplast A/S
Erectile Dysfunction
02/32
02/32
Wilton, James
HyPeR, NCT02998567: Combination Study of Guadecitabine/ASTX727 and Pembrolizumab

Recruiting
1
34
Europe
Guadecitabine, Pembrolizumab, ASTX727
Royal Marsden NHS Foundation Trust, Astex Pharmaceuticals, Inc., Merck Sharp & Dohme LLC, Institute of Cancer Research, United Kingdom
Castration-Resistant Prostatic Cancer, Non Small Cell Lung Cancer
09/26
09/26
Werring, David
PROHIBIT-ICH, NCT03863665: Prevention of Hypertensive Injury to the Brain by Intensive Treatment of Blood Pressure After Intracerebral Haemorrhage

Terminated
N/A
86
Europe
A&D BP Digital Blood Pressure Monitor (UA-767PBT-Ci) CE Declaration UA-767PBT-Ci
University College, London, University of Oxford, The Stroke Association, United Kingdom
Intracerebral Hemorrhage
05/22
04/23
OPTIMAS, NCT03759938: OPtimal TIMing of Anticoagulation After Acute Ischaemic Stroke : a Randomised Controlled Trial

Active, not recruiting
N/A
3648
Europe
Direct oral anticoagulant (DOAC), dabigatran, apixaban, edoxaban, rivaroxaban
University College, London
Stroke, Acute, Atrial Fibrillation
05/24
10/24
SLSR, NCT05298436: The South London Stroke Register: Improving the Lives of Stroke Survivors With Data

Recruiting
N/A
2000
Europe
Follow-up interview
Guy's and St Thomas' NHS Foundation Trust
Stroke, Subarachnoid Hemorrhage, Intracranial Hemorrhages
12/26
12/26
@neurIST, NCT05526352: : Intregrated Biomedical Informatics for the Management of Cerebral Aneurysms

Recruiting
N/A
20000
Europe, Canada, US
University Hospital, Geneva, University of Geneva, Switzerland, Klinik Hirslanden, Zurich
Intracranial Aneurysm
03/40
03/40
Ralph, David
PHOENIX, NCT03849586: Registry for Patients Undergoing Penile Prosthesis Implantation for Male Erectile Dysfunction

Active, not recruiting
N/A
1076
Europe
European Association of Urology Research Foundation, Boston Scientific Corporation, Coloplast A/S
Erectile Dysfunction
02/32
02/32
Strauss, Sandra
SPEARHEAD-1, NCT04044768 / 2019-000589-39: Spearhead 1 Study in Subjects With Advanced Synovial Sarcoma or Myxoid/Round Cell Liposarcoma

Oct 2022 - Jun 2023: BLA submission for treatment of synovial sarcoma
Checkmark Data from cohort 1 of SPEARHEAD-1 trial for synovial sarcoma or myxoid round cell liposarcoma
Nov 2022 - Nov 2022: Data from cohort 1 of SPEARHEAD-1 trial for synovial sarcoma or myxoid round cell liposarcoma
Checkmark Pooled analysis data from trials for sarcoma at AACR 2022
Jun 2022 - Jun 2022: Pooled analysis data from trials for sarcoma at AACR 2022
More
Active, not recruiting
2
52
Europe, Canada, US
afamitresgene autoleucel (previously ADP-A2M4)
Adaptimmune, Adaptimmune LLC
Synovial Sarcoma, Myxoid Liposarcoma
08/21
04/38
ChonDRAgon, NCT04950075: Study of INBRX-109 in Conventional Chondrosarcoma

Recruiting
2
201
Europe, US, RoW
INBRX-109, Placebo
Inhibrx Biosciences, Inc
Conventional Chondrosarcoma
09/25
12/26
CAMPFIRE, NCT05999994: A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer

Recruiting
2
105
Europe, Japan, US, RoW
Ramucirumab, LY3009806, Cyclophosphamide, Vinorelbine, Gemcitabine, LY188011, Docetaxel, Abemaciclib, LY2835219, Irinotecan, Temozolomide
Eli Lilly and Company
Neoplasms, Child, Adolescent
05/27
05/27
ImmunoSarc, NCT03277924 / 2016-004040-10: Trial of Sunitinib and/or Nivolumab Plus Chemotherapy in Advanced Soft Tissue and Bone Sarcomas

Completed
1/2
197
Europe
Sunitinib 37.5 MG, Sunitinib 25 MG [Sutent], Sutent, Nivolumab 100 MG/10 ML [Opdivo], Opdivo, Epirubicin, Ifosfamide, Doxorubicin, Dacarbazine, Cisplatin, Methotrexate
Grupo Espanol de Investigacion en Sarcomas
Soft Tissue Sarcoma, Bone Sarcoma
06/24
06/24
NCT03715933: Phase 1 Study of INBRX-109 in Subjects with Locally Advanced or Metastatic Solid Tumors Including Sarcomas

Recruiting
1
321
Europe, US
INBRX-109, Carboplatin, Cisplatin, Pemetrexed, 5-fluorouracil, Irinotecan, Temozolomide
Inhibrx Biosciences, Inc
Colorectal Adenocarcinoma, Ewing Sarcoma
06/26
12/26
SCOOP, NCT04544995 / 2020-002359-39: Dose Escalation and Cohort Expansion Study of Niraparib and Dostarlimab in Paediatric Participants With Solid Tumors

Recruiting
1
141
Europe, RoW
Niraparib, Dostarlimab
GlaxoSmithKline
Neoplasms
10/29
05/30
NCT03391778 / 2018-004888-31: Adoptive Cell Therapy Long-term Follow-up (LTFU) Study

Recruiting
1
250
Europe, Canada, US, RoW
ADP adoptive cell therapy
Adaptimmune
Neoplasms
04/32
04/32
ICONIC, NCT04132895: Improving Outcomes Through Collaboration in OsteosarComa

Recruiting
N/A
300
Europe
observational only, no interventions are prescribed in protocol.
University College, London, Bone Cancer Research Trust
Osteosarcoma
01/25
01/27
Batterham, Rachel L
BARI-STEP, NCT05073835: Semaglutide 2.4 mg in Patients With Poor Weight-loss

Active, not recruiting
3
70
Europe
Semaglutide 3 mg, Placebo
University College, London
Obesity, Diabetes, Metabolic Syndrome
03/25
09/25
UPDATE, NCT05627570: A Study Comparing the Health Effects of Two Diets Following UK Dietary Guidance in People Living with Overweight or Obesity

Active, not recruiting
N/A
55
Europe
Healthy, balanced Diet A, Healthy, balanced Diet B, Behavioural support intervention
University College, London, University College London Hospitals
Obesity, Cardiometabolic Syndrome, Overweight
10/24
05/25
Ellerton, Charlotte
Maternal PKU, NCT04224142: Evaluation of PKU Sphere in

Active, not recruiting
N/A
11
Europe
PKU sphere
Vitaflo International, Ltd, University College London Hospitals
Maternal Phenylketonuria
06/25
06/25
Papadatos-Pastos, Dionysis
NERO, NCT05455424: Niraparib Efficacy in Patient With Unresectable Mesothelioma

Active, not recruiting
2
88
Europe
Niraparib Oral Product, Zejula, Active Symptom Control
University Hospital Southampton NHS Foundation Trust, University of Southampton, British Lung Foundation
Mesothelioma, Malignant
12/24
12/24
CRUKD/17/009, NCT03486730 / 2016-004633-24: BT1718 in Patients with Advanced Solid Tumours.

Hourglass Jun 2022 - Dec 2022 : Updated data for solid tumors
Completed
1/2
72
Europe
BT1718
Cancer Research UK, Bicycle Therapeutics
Advanced Solid Tumours, Non-Small Cell Lung Cancer, Non-Small Cell Lung Sarcoma, Oesophageal Cancer
11/23
11/23
HyPeR, NCT02998567: Combination Study of Guadecitabine/ASTX727 and Pembrolizumab

Recruiting
1
34
Europe
Guadecitabine, Pembrolizumab, ASTX727
Royal Marsden NHS Foundation Trust, Astex Pharmaceuticals, Inc., Merck Sharp & Dohme LLC, Institute of Cancer Research, United Kingdom
Castration-Resistant Prostatic Cancer, Non Small Cell Lung Cancer
09/26
09/26
TRACERx, NCT01888601: TRAcking Non-small Cell Lung Cancer Evolution Through Therapy (Rx)

Active, not recruiting
N/A
814
Europe
University College, London, Cancer Research UK
Non-small Cell Lung Cancer
12/26
12/26
Robinson, Anna
PROHIBIT-ICH, NCT03863665: Prevention of Hypertensive Injury to the Brain by Intensive Treatment of Blood Pressure After Intracerebral Haemorrhage

Terminated
N/A
86
Europe
A&D BP Digital Blood Pressure Monitor (UA-767PBT-Ci) CE Declaration UA-767PBT-Ci
University College, London, University of Oxford, The Stroke Association, United Kingdom
Intracerebral Hemorrhage
05/22
04/23
ATHN 9, NCT03853486: Severe VWD Natural History Study

Active, not recruiting
N/A
108
US
American Thrombosis and Hemostasis Network, Takeda
Von Willebrand Diseases
12/24
01/25
Hiley, Crispin
CONCORDE, NCT04550104: A Platform Study of Novel Agents in Combination With Radiotherapy in NSCLC

Recruiting
1
200
Europe
Radiotherapy, Olaparib Oral Tablet [Lynparza], AZD2281, AZD1390, Ceralasertib, AZD6738, AZD5305, Durvalumab
University of Leeds, University of Manchester, Newcastle University, University of Oxford, The Leeds Teaching Hospitals NHS Trust, Beatson West of Scotland Cancer Centre, University of Glasgow, Velindre NHS Trust, University College London Hospitals, Queen's University, Belfast, University of Sheffield
Non Small Cell Lung Cancer
04/25
03/28
SARON, NCT02417662: Stereotactic Ablative Radiotherapy for Oligometastatic Non-small Cell Lung Cancer

Active, not recruiting
N/A
340
Europe
Radical Radiotherapy (Conventional RT and SABR), Non-investigational SACT
University College, London, Cancer Research UK
Non-small Cell Lung Cancer
08/25
08/28
HIT-Meso, NCT05655078: Hemithoracic Irradiation With Proton Therapy in Malignant Pleural Mesothelioma

Recruiting
N/A
148
Europe
Proton beam therapy
University College, London, Asthma + Lung UK, Mesothelioma UK, University of Sheffield
Malignant Pleural Mesothelioma
03/29
09/29
Minchom, Anna
MATINS, NCT03733990 / 2018-002732-24: A Study to Evaluate Safety, Tolerability and Preliminary Efficacy of FP-1305 in Cancer Patients

Completed
1/2
216
Europe, US
FP-1305 (bexmarilimab), bexmarilimab
Faron Pharmaceuticals Ltd
Cancer
09/23
10/23
RAMP 203, NCT05074810: Phase 1/2 Study of Avutometinib (VS-6766) + Sotorasib With or Without Defactinib in KRAS G12C NSCLC Patients

Recruiting
1/2
153
Europe, US
avutometinib and sotorasib, AMG 510, LUMAKRAS™, VS-6766, avutometinib and sotorasib and defactinib, VS-6063
Verastem, Inc., Amgen
Non Small Cell Lung Cancer, KRAS Activating Mutation
09/25
04/27
LIBRETTO-001, NCT03157128 / 2017-000800-59: A Study of Selpercatinib (LOXO-292) in Participants With Advanced Solid Tumors, RET Fusion-Positive Solid Tumors, and Medullary Thyroid Cancer

Hourglass Apr 2022 - Dec 2022 : Approval in China for RET+NSCLC, medullary thyroid cancer and thyroid cancer
Hourglass Jan 2022 - Dec 2022 : Submission for lung cancer
Checkmark From LIBRETTO-001 trial in RET fusion-positive NSCLC
Aug 2020 - Aug 2020: From LIBRETTO-001 trial in RET fusion-positive NSCLC
Checkmark Granted for advanced RET fusion+ve 2L thyroid cancer [LIBRETTO-001]
More
Active, not recruiting
1/2
856
Europe, Canada, Japan, US, RoW
LOXO-292, Selpercatinib, LY3527723
Loxo Oncology, Inc., Eli Lilly and Company
Non-Small Cell Lung Cancer, Medullary Thyroid Cancer, Colon Cancer, Any Solid Tumor
02/25
02/26
ALKOVE-1, NCT05384626 / 2022-000122-21: A Study of NVL-655 in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation

Recruiting
1/2
470
Europe, Canada, Japan, US, RoW
NVL-655
Nuvalent Inc., Nuvalent, Inc.
Locally Advanced Solid Tumor, Metastatic Solid Tumor
02/26
03/26
SGNALPV-001, NCT05229900: A Study of SGN-ALPV in Advanced Solid Tumors

Terminated
1
43
Europe, Canada, US
SGN-ALPV
Seagen Inc.
Ovarian Neoplasms, Endometrial Neoplasms, Carcinoma, Non-Small-Cell Lung, Stomach Neoplasms, Gastroesophageal Junction Carcinoma, Uterine Cervical Neoplasms, Testicular Neoplasms
12/23
12/23
SGNTGT-001, NCT04254107: A Safety Study of SEA-TGT (SGN-TGT) in Advanced Cancer

Terminated
1
132
Europe, Canada, US
SEA-TGT, SGN-TGT, sasanlimab, brentuximab vedotin, Adcetris
Seagen Inc.
Non-small Cell Lung Cancer, Gastric Carcinoma, Gastroesophageal Junction Carcinoma, Classical Hodgkin Lymphoma, Diffuse Large B-cell Lymphoma, Peripheral T-cell Lymphoma, Cutaneous Melanoma, Head and Neck Squamous Cell Carcinoma, Bladder Cancer, Ovarian Cancer, Triple Negative Breast Cancer, Cervical Cancer
12/23
12/23
SGNSTNV-001, NCT04665921: A Study of SGN-STNV in Advanced Solid Tumors

Terminated
1
111
Europe, Canada, US
SGN-STNV
Seagen Inc.
Carcinoma, Non-Small Cell Lung, HER2 Negative Breast Neoplasms, Ovarian Neoplasms, Uterine Cervical Neoplasms, Endometrial Neoplasms, Esophageal Neoplasms, Gastroesophageal Junction Carcinoma, Stomach Neoplasms, Colorectal Neoplasms, Exocrine Pancreatic Adenocarcinoma, Appendiceal Adenocarcinoma, Pseudomyxoma Peritonei
03/24
03/24
SGNPDL1V-001, NCT05208762: A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors

Recruiting
1
438
Europe, Canada, US
PF-08046054, SGN-PDL1V, pembrolizumab, Keytruda
Seagen Inc.
Carcinoma, Non-Small-Cell Lung, Squamous Cell Carcinoma of the Head and Neck, Esophageal Squamous Cell Carcinoma, Ovarian Neoplasms, Melanoma, Triple Negative Breast Neoplasms, Gastric Cancer
07/25
12/27
HyPeR, NCT02998567: Combination Study of Guadecitabine/ASTX727 and Pembrolizumab

Recruiting
1
34
Europe
Guadecitabine, Pembrolizumab, ASTX727
Royal Marsden NHS Foundation Trust, Astex Pharmaceuticals, Inc., Merck Sharp & Dohme LLC, Institute of Cancer Research, United Kingdom
Castration-Resistant Prostatic Cancer, Non Small Cell Lung Cancer
09/26
09/26
POTENT, NCT05782361: - Tepotinib in Combination with Pembrolizumab in NSCLC

Recruiting
1
38
Europe
Tepotinib, Pembrolizumab, MK-3475
Institute of Cancer Research, United Kingdom, Merck Healthcare KGaA
Advanced Cancer, Non Small Cell Lung Cancer
02/28
02/28
TARGET National, NCT04723316: Tumour Characterisation to Guide Experimental Targeted Therapy - National

Recruiting
N/A
6000
Europe
The Christie NHS Foundation Trust
Cancer
01/26
01/28
Chakraverty, Ron
ToTem, NCT03836690: Transfer of Effector Memory T Cells (Tem) Following Allogeneic Stem Cell Transplantation

Recruiting
1
18
Europe
CD62L- Tem
University College, London, Medical Research Council
Lymphoma, Leukemia, Myeloma, Myelodysplastic Syndromes, Severe Aplastic Anemia, Primary Immune Deficiency, Graft Vs Host Disease
07/22
04/23
Thakrar, Ricky
DOLCE, NCT05389774: Determining the Impact of Optellum's Lung Cancer Prediction Solution

Recruiting
N/A
2000
Europe
Nottingham University Hospitals NHS Trust, Optellum Ltd.
AI (Artificial Intelligence), Pulmonary Nodule, Solitary, Pulmonary Nodule, Multiple, Lung Cancer
01/25
01/25
Williams, B
NCT04750356: SARS-CoV-2 (COVID-19) Longitudinal Study: Understanding Susceptibility, Transmission and Disease Severity (Legacy Study)

Recruiting
N/A
6000
Europe
University College, London, The Francis Crick Institute
SARS-CoV Infection
12/24
12/24
Khaw, Chuen Ryan Dr
ASCENT, NCT04204499: Analysis of Screen-detected Lung Cancers' Genomic Traits

Recruiting
N/A
526
Europe
University College, London
Lung Cancer
08/25
03/26
ALPINE, NCT05902559: Assessment of Novel Biomarkers in Participants Undergoing Targeted Lung Health Checks

Recruiting
N/A
10000
Europe
University College, London, Gustave Roussy, Cancer Campus, Grand Paris
Lung Cancer
11/27
11/28
Koskela, Lotta Renström
NCT06115083: Effects of Pelvic Floor Training in Male Chronic Pelvic Pain, Correlation Between Subjective and Objective Outcomes

Recruiting
N/A
40
Europe
Pelvic floor re-education using bio-feedback and home training
Region Stockholm, Karolinska Institutet
Chronic Pelvic Pain Syndrome, Chronic Prostatitis With Chronic Pelvic Pain Syndrome, Chronic Prostatitis, Pelvic Floor; Relaxation
12/26
12/26
PHOENIX, NCT03849586: Registry for Patients Undergoing Penile Prosthesis Implantation for Male Erectile Dysfunction

Active, not recruiting
N/A
1076
Europe
European Association of Urology Research Foundation, Boston Scientific Corporation, Coloplast A/S
Erectile Dysfunction
02/32
02/32
Vaz, Francis Mr
HANSOM, NCT06322160: The Role of tHyroid cAncer Specific Patient Concerns iNventory (PCI-TC) in Enhancing Shared decisiOn Making

Completed
N/A
19
Europe
Interview
Royal Marsden NHS Foundation Trust, ENT UK
Thyroid Cancer
09/24
09/24

Download Options